The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about "several hundred units" of the drug ...

The maker of Ozempic and the weight loss drug Wegovy told the FDA on April 3 that counterfeit 1-milligram injections were ...

UBT251 is different from Novo Nordisk’s current drugs like Ozempic and Wegovy. The drug combines GLP-1 and GIP, which lower appetite and blood sugar, with glucagon, which helps prevent ...

Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

In the fourth quarter of 2024, Ozempic sales increased 12% to 33.85 billion Danish kroner, and Wegovy sales more than doubled to 19.87 billion Danish kroner. Also Read: Novo Nordisk Shares Data ...

Investing.com -- Barclays (LON:BARC) has lowered its first-quarter 2025 estimates for Novo Nordisk (CSE:NOVOb) (NYSE:NVO) ahead of its Q1 2025 report, citing weaker-than-expected prescription volumes ...

Investing.com -- Barclays has lowered its first-quarter 2025 estimates for Novo Nordisk (CSE ... prescription volumes for key drugs Wegovy and Ozempic in the U.S. The investment bank now expects ...

Eli Lilly’s weight-loss drugs, Zepbound and Mounjaro, directly rival Novo Nordisk’s Wegovy and Ozempic, intensifying the competitive landscape. Year-to-date, Novo’s shares have dropped 25%, while ...

Ozempic improved maximum walking distance by 13% in peripheral artery disease patients over 52 weeks. Rybelsus reduced the risk of major cardiovascular events by 14% in high-risk patients.

The deal comes as Novo Nordisk moves to become the leader in ... The Danish maker of Ozempic has dominated the space with its Wegovy, but is facing competition from Eli Lilly's Zepbound (tirzepatide).

They are Ozempic, Wegovy, Rybelsus, NovoRapid, and NovoSeven, whose combined sales reached about DKK 68.54 billion [80% of Novo Nordisk's total revenue] in the last three months of 2024 ...

Novo Nordisk (NVO) announced on Saturday that a late-stage trial for its popular weight loss therapy Ozempic in adults with type 2 diabetes and a vascular disorder known as peripheral artery ...